Meet Dr Marc Liebscher, the German White Knight riding to rescue of Steinhoff's retail shareholders

Loading player...
Steinhoff's management and board were given a bloody nose at December's Annual General Meeting when all the important proposals were voted down because of the opposition of Germany's leading Shareholder Protection association SDK. The investment activist body, established in the 1950s, boasts numerous coups including imploded multinational Wirecard. It speaks for shareholders representing 23% of Steinhoff's equity - and board member Dr Marc Liebscher says it wants to add South Africans to the 1800 German shareholders who have already proved to be the Nemesis of Steinhoff's managers. By voting against the proposals, SDK says it stopped a board proposal that would have seen already in-the-money financial speculators profiting further while shareholders would lose virtually everything. Berlin-based lawyer Liebscher says SDK is well-funded and up for a fight. Among its options is calling a meeting to replace the Steinhoff board and its well-paid (R50m a year) managers who, he believes, appear to be acting for hedge funds and other creditors rather than in the interests of shareholders. He spoke to Alec Hogg of BizNews. Learn more about your ad choices. Visit megaphone.fm/adchoices
3 Apr 2023 4AM English South Africa Investing · Business News

Other recent episodes

Joburg audit setback exposes R9.5bn bad debt burden

Johannesburg’s financial crisis is deepening, with the Auditor-General revealing R9.5 billion in losses driven largely by electricity theft, water leaks and weak governance. An infrastructure backlog now estimated at R200 billion threatens service delivery in South Africa’s economic powerhouse. Analysts warn that years of poor oversight, mounting debt and a…
5 Jun 5AM 7 min

Ebola outbreak in DRC grabs global attention - perfect storm of war, fear, and disease

John McDermott explores the unfolding Ebola outbreak in eastern Democratic Republic of Congo, unpacking how transmission occurs, why the crisis is spreading, and what makes this strain particularly dangerous. He examines strained health systems, limited aid funding, and the challenge of vaccine development. The discussion situates the outbreak within broader…
4 Jun 7AM 26 min